Lakefront Biotherapeutics | GLPG - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
argenx SE USD 403.29M 17.24M 2025-12
AstraZeneca USD 3.91B 1.28B 2026-03
Biogen USD 377.7M 433.7M 2026-03
Genmab DKK 55M 427M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Incyte USD 343.6M 46.34M 2026-03
Merck EUR 401M 886.1M 2025-12
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 3.84B 802M 2026-03
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03